Lecture image placeholder

Premium content

Access to this content requires a subscription. You must be a premium user to view this content.

Monthly subscription - $9.99Pay per view - $4.99Access through your institutionLogin with Underline account
Need help?
Contact us
Lecture placeholder background
VIDEO DOI: https://doi.org/10.48448/8jyn-n098

technical paper

ENDO 2021

March 21, 2021

Live on Underline

Long-Term Control of Urinary Free Cortisol with Osilodrostat in Patients with Cushing's Disease: Final Results from the LINC 2 Study

Please log in to leave a comment

Downloads

Transcript English (automatic)

Next from ENDO 2021

Pharmacokinetics and Safety of an Improved Oral Formulation of Paltusotine, a Selective, Nonpeptide Somatostatin Receptor 2 (SST2) Agonist for the Treatment of Acromegaly
technical paper

Pharmacokinetics and Safety of an Improved Oral Formulation of Paltusotine, a Selective, Nonpeptide Somatostatin Receptor 2 (SST2) Agonist for the Treatment of Acromegaly

ENDO 2021

21 March 2021

Similar lecture

Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma
technical paper

Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma

ENDO 2021

21 March 2021

Stay up to date with the latest Underline news!

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved